技術・研究開発｜株式会社トランスジェニックグループ

This page outlines the technology and R&D initiatives of Transgenic Group Inc., a drug discovery support company. The company provides unique tools including genetically modified animals, non-clinical testing, and genetic analysis. While genome analysis technology has advanced significantly, a critical gap remains between genes and disease causality, requiring viable animal models for experimentation. To bridge the gap between humans and animals, the company focuses on developing "humanized mice" technology. Key developments include transgenic mice, knockout mice, and CRISPR/Cas9 genome editing techniques, all aimed at advancing medical progress and human health.